Glaxo, Watson Strike $35M Deal Over Wellbutrin
Andrx Corp. first lodged the infringement suit in the U.S. District Court for the Southern District of Florida in December 2005. Andrx was acquired by Watson in November 2006.
Under the settlement agreement, Andrx will receive a one-time payment of $35 million, and grant GlaxoSmithKline a royalty-bearing license for the billion-dollar drug. The other terms of...
To view the full article, register now.